Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
| Newest: Dietary supplements and patient counseling |
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
Survey
|
|
This month we would like to know...
Do you carry personal malpractice insurance, in addition to the coverage provided by your employer?
• I am a community pharmacist and I do not carry personal malpractice insurance.
• I am a community pharmacist, and I do carry personal malpractice insurance.
• I am a health-system pharmacist and I do not carry personal malpractice insurance.
• I am a health-system pharmacist and I do carry personal malpractice insurance.
|
|
|
The Obama administration recently unveiled a multiagency plan to reduce the "epidemic" of prescription drug abuse in the United States. Read full article. |
 |
|
|
To confirm your e-newsletter subscription, click here.
To ensure future delivery of email newsletters from
Drug Topics, please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff
|
 |
A discussion generated by
Drug Topics’ readers, editorial staff, and advisory board
Norb Salamonski is a community chain-store pharmacist in Marshfield, Wis. |
The upside of efficiency
Read full article.
|
FDA recently issued warning letters to companies that manufacture and market over-the-counter products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylocococcus aureus. Read full article. |
|
Fingolimod (Gilenya, Novartis) reduced the risk of disability progression in patients with RRMS, regardless of treatment history, according to a study reported at the 63rd annual meeting of the American Academy of Neurology. Read full article. |
|
|
Roche recently recalled its Accu-Chek FlexLink Plus infusion sets globally because they may deliver insufficient amounts of insulin to patients. Read full article.
 |
Meetings and Events
April 27-30, 2011 AMCP's 23rd Annual Meeting & Showcase
Minneapolis, MN
Contact:
100 North Pitt Street Suite 400
Alexandria, VA 22314
800-827-2627; 703-683-8416
April 30-May 3, 2011 NACDS Annual Meeting
Scottsdale, AZ
Contact:
P.O. Box 34814
Alexandria, Virginia 22334-0814
703-837-4300
May 17-19, 2011 ASCP Spring Conference + Exhibition (formerly known as the ASCP Midyear Conference)
Las Vegas, Nevada
Contact:
Alexandria, VA 22314
Phone: 703-739-1300 or 800-355-2727
Fax: 703-739-1321 or 800-220-1321
[email protected]
May 23-25, 2011 NCPA Legislative Conference
Washington, DC
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
June 1-2, 2011 PQA Annual Meeting
Washington, DC
Contact:
Karen Peterson
9687 South Run Oaks Drive
Fairfax Station, VA 22039
Fax: 703-690-1756
[email protected]
June 2-3 PQA/URAC Medication Adherence Summit
Washington, DC
Contact:
Jackie Green
1220 L Street NW, Suite 400
Washington, DC 20005
703-927-1599
[email protected]
|
|
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
